Please sign in to follow a disease.
Xeroderma pigmentosum group F
MONDO:0010215Any xeroderma pigmentosum in which the cause of the disease is a mutation in the ERCC4 gene.
Also known as: ERCC4 xeroderma pigmentosum, XP, group F, XP-F, XP6, XPF, xeroderma pigmentosum caused by mutation in ERCC4, xeroderma pigmentosum group F, xeroderma pigmentosum group type F
4 clinical trials for this condition and its sub-types, 1 tagged with Xeroderma pigmentosum group F itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Gene therapy offers hope for babies with 'Bubble Boy' disease
Cure Recruiting nowThis study tests a new gene therapy for children with a severe immune disorder called Artemis-SCID, where the body cannot fight infections. Doctors take the child's own blood stem cells, fix the faulty gene in a lab, and put the corrected cells back. The goal is to rebuild a work…
Phase 1/2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Cure
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called AZD4956, alone or with other cancer drugs, in people with advanced or spreading solid tumors that have a specific DNA repair defect (HRR deficiency). The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. …
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC